Thermo Fisher Scientific
TMO
2,568 hedge funds and large institutions have $208B invested in Thermo Fisher Scientific in 2024 Q3 according to their latest regulatory filings, with 170 funds opening new positions, 1,034 increasing their positions, 993 reducing their positions, and 116 closing their positions.
47% more first-time investments, than exits
New positions opened: 170 | Existing positions closed: 116
11% more capital invested
Capital invested by funds: $187B → $208B (+$20.5B)
2% more funds holding in top 10
Funds holding in top 10: 114 → 116 (+2)
1% more funds holding
Funds holding: 2,542 → 2,568 (+26)
4% more repeat investments, than reductions
Existing positions increased: 1,034 | Existing positions reduced: 993
0.35% less ownership
Funds ownership: 88.87% → 88.52% (-0.35%)
13% less call options, than puts
Call options by funds: $1.59B | Put options by funds: $1.82B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$837M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$766M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$620M |
| 4 |
JP Morgan Chase
New York
|
+$582M |
| 5 |
AIM
Alphinity Investment Management
Sydney,
Australia
|
+$555M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$566M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$483M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$294M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$276M |
| 5 |
Millennium Management
New York
|
-$262M |
TMO Hedge Fund Activity: Q3 2024 in Review
2,568 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2024, worth a combined $208B — up 11% from $187B a quarter earlier.
Buyers outnumbered sellers: 170 funds opened new TMO positions and 116 closed out — a net gain of 54 holders — while 1,034 added to existing stakes and 993 trimmed.
The largest buyer was International Assets Investment Management, adding an estimated $837M. The largest seller was Morgan Stanley, cutting an estimated $566M.
- 2,568 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2024, up from 2,542 in Q2 2024.
- Funds reported $208B of Thermo Fisher Scientific stock for Q3 2024, up 11% quarter-over-quarter.
- 170 funds opened new Thermo Fisher Scientific positions in Q3 2024 and 116 closed out, a net change of +54 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2024 was International Assets Investment Management, an estimated $837M added.
- The largest Thermo Fisher Scientific seller in Q3 2024 was Morgan Stanley, an estimated $566M sold.
Based on aggregated 13F filings for Q3 2024.